Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre N Tariot

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Evidence-Based Mental Health|January 27, 2005
Review: atypical antipsychotics may be useful in treating behavioural and psychological symptoms of dementia but cause adverse effectsPierre N Tariot
Psychopharmacology Bulletin|March 17, 2004
Valproate use in neuropsychiatric disorders in the elderlyPierre N Tariot
The Journal of Clinical Psychiatry|April 12, 2008
Psychosis and agitation in dementia: should general psychiatrists care?Pierre N Tariot
CNS Spectrums|August 24, 2007
Clinical trials of amyloid-based therapies for Alzheimer's diseasePierre N Tariot
Journal of the American Geriatrics Society|June 13, 2003
Medical management of advanced dementiaPierre N Tariot
JAMA|May 12, 2005
Pharmacological treatment of neuropsychiatric symptoms of dementiaPierre N Tariot
The Lancet. Neurology|May 31, 2014
When should neuroprotective drugs move from mice to men?Pierre N Tariot
Alzheimer Disease and Associated Disorders|September 27, 2003
Alzheimer disease: current challenges, emerging treatmentsPierre N Tariot
The Journal of Clinical Psychiatry|July 22, 2004
Clinical effectiveness of atypical antipsychotics in dementiaPierre N Tariot
The Journal of Clinical Psychiatry|May 3, 2006
Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapiesPierre N Tariot
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Evidence-Based Mental Health|January 27, 2005
Review: atypical antipsychotics may be useful in treating behavioural and psychological symptoms of dementia but cause adverse effectsPierre N Tariot
Psychopharmacology Bulletin|March 17, 2004
Valproate use in neuropsychiatric disorders in the elderlyPierre N Tariot
The Journal of Clinical Psychiatry|April 12, 2008
Psychosis and agitation in dementia: should general psychiatrists care?Pierre N Tariot
CNS Spectrums|August 24, 2007
Clinical trials of amyloid-based therapies for Alzheimer's diseasePierre N Tariot
Journal of the American Geriatrics Society|June 13, 2003
Medical management of advanced dementiaPierre N Tariot
JAMA|May 12, 2005
Pharmacological treatment of neuropsychiatric symptoms of dementiaPierre N Tariot
The Lancet. Neurology|May 31, 2014
When should neuroprotective drugs move from mice to men?Pierre N Tariot
Alzheimer Disease and Associated Disorders|September 27, 2003
Alzheimer disease: current challenges, emerging treatmentsPierre N Tariot
The Journal of Clinical Psychiatry|July 22, 2004
Clinical effectiveness of atypical antipsychotics in dementiaPierre N Tariot
The Journal of Clinical Psychiatry|May 3, 2006
Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapiesPierre N Tariot
Pageof 16